slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
239,461-239,490 of 319,975
01
Instacart | Product Presentation Deck | 20 slidesInstacart | Product Presentation Deck | 20 slides · Instacart
Conference presentation Investor relations 1 hit
02
Uses a simple additive equation format to define the service offering.Instacart | Product Presentation Deck | 20 slides · Instacart
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
03
Includes a humorous photo of a cat in an Instacart bag as the final step.Instacart | Product Presentation Deck | 20 slides · Instacart
Conference presentation Investor relations 1 hit
04
The slide uses a sequence of screenshots to illustrate the user journey.Instacart | Product Presentation Deck | 20 slides · Instacart
Conference presentation Investor relations 1 hit
05
The diagram uses a hub-and-spoke style layout to show bidirectional flows between the four entities.Instacart | Product Presentation Deck | 20 slides · Instacart
Conference presentation Investor relations 1 hit
06
Uses a mix of market data, social proof, and a comparative visual for unit economics.Instacart | Product Presentation Deck | 20 slides · Instacart
Conference presentation Investor relations 1 hit
07
Uses icons to represent revenue (green +$) and cost (red -$) components.Instacart | Product Presentation Deck | 20 slides · Instacart
Conference presentation Investor relations Beat · Solution & Approach1 hit
08
The chart uses an area fill to represent the trend of fulfillment time reduction.Instacart | Product Presentation Deck | 20 slides · Instacart
Conference presentation Investor relations Beat · Solution & Approach1 hit
67
Includes a standard Theranos FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
68
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
69
The slide includes a disclaimer that the technology is not FDA cleared.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
70
The slide highlights the third section with a teal background, indicating it is the current or focus topic.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
71
This slide outlines technical parameters for blood collection, likely part of a methodology or process overview.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
72
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
73
This slide outlines technical mitigation strategies for blood sample collection issues.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
74
The slide describes the mechanical process of the Theranos nanotainer system.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
75
The slide illustrates the mechanical process of blood collection and sample preparation.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
76
The image shows a Theranos-branded blood collection device (nanotainer).Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
77
Includes FDA disclaimer at the bottom.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
78
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Results1 hit
79
The slide uses a standard table format to define the parameters of a clinical validation study.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
80
The slide includes a disclaimer that the technology is not FDA cleared.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
81
Passing-Bablok regression used for analysis.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
82
This slide is from a Theranos presentation, likely used to establish the scientific rigor of their testing methodology.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
83
The slide presents clinical validation data for the Theranos miniLab device.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
84
Passing-Bablok regression used for analysis.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
85
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
86
The slide presents clinical validation data for a diagnostic assay.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
87
Includes disclaimer at the bottom regarding FDA status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit
88
Theranos | Investor Conference Presentation Deck | 88 slidesTheranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Conclusion1 hit